Belgium

Biobank of CHU UCL Namur

Biobank of CHU UCL Namur aims to promote collaborative research with academia and industries.
Activities are focused on neoplastic and inflammatory disease. Our biobank has also a tropism for haematological pathologies (leukemia, lymphoma,..).
Differents samples type are prospectively collected (blood derivatives, solid tissues, bone marrow) and available at differents type points of the disease
Collaborative projects are enhanced with the possibility to create a specific collection in consultation with clinical researchers

Key facts

Name of the connected EIT Health partner:
Number of individuals: 5000
Biobank confirmed willingness to provide samples/data for EIT Health studies: Yes. Submission of the project to scientific and ethic’s committee Quotation HMTA
Contact person(s) and contact data
(e-mail address, tel. no) for access purposes:		 Fabienne George, fabienne.george@uclouvain.be, +3281424495; Carlos Graux, carlos.graux@uclouvain.be, +3281424764
Number of samples:
Sample type: Tissue, Whole blood, Buffy Coat, Plasma, Serum, Cells, DNA, RNA
Website: http://www.uclmontgodinne.be
Website: BWB: https://biotheque-wallonie-bruxelles.be/en

General information

Type of biobank: Clinical/disease specific;Residual/secondary use;Case-control. Neoplastic, immunological and inflammatory disease collection
If longitudinal the frequency:
Link to central portal to seek samples and data:
Broad consent: Yes
Option to recall donors: No
Option to recall family members: No

Biobank access procedure:

Major terms for access: Submission of the project to scientific and ethic’s committee
Ethical and legal compliance: Submission to scientific and ethic’s committee. Belgian law of 19.12.2008 with royal decrees of 09.01.2018
GDPR 27.04.2016
Speed and reliability of delivery: 1-2 months
Pricing: Depending of the request

Quality management system:

Storage: Data: Modul bio LIM’s
Sample: Liquid nitrogen tanks, -80°C freezers with temperature monitoring and back up
Compliance with international standards: ISBER guidelines
Current ISO certificates: ISO 9001:2015 certification

Data:

Clinical data linked to samples: Clinical data, https://virtualtumourbank.kankerregister.org/tumourbank.aspx?lang=TB_EN
Data standards: Specific eCRF according to the pathology
Data security rules: Pseudo anonymised data

Biobank related service:

Research support, what type of expertise?: Possibility to create a prospective collection in collaboration with clinical reseachers
Core facility services; what type? Link?:
Queries from national health registers:
Links to the model contract and MTA:

IP:

IP rules, what is negotiable?: To discuss in function of the request
Requirements to study results (access etc.):
Participant’s right to the information: No rights. Significants results only transmit to their physician
Number of access contracts with industry:

COVID-19 samples:

Access to biological samples from patients with COVID-19?

  • Serum
  • Full blood (for RNA extraction)
  • EDTA-Full blood (for DNA extraction)
  • EDTA-Plasma
  • Citrate-Plasma
  • PBMC (Peripheral Blood Mononuclear Cells)
  • Nasopharyngeal aspirate
  • Tracheal aspirate
Contact person(s) and contact data (e-mail address, tel. no) for access purposes